Correlation Between Lantern Pharma and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Foghorn Therapeutics, you can compare the effects of market volatilities on Lantern Pharma and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Foghorn Therapeutics.
Diversification Opportunities for Lantern Pharma and Foghorn Therapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lantern and Foghorn is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Lantern Pharma and Foghorn Therapeutics
Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the Foghorn Therapeutics. In addition to that, Lantern Pharma is 1.14 times more volatile than Foghorn Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Foghorn Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 804.00 in Foghorn Therapeutics on August 31, 2024 and sell it today you would lose (25.00) from holding Foghorn Therapeutics or give up 3.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lantern Pharma vs. Foghorn Therapeutics
Performance |
| Timeline |
| Lantern Pharma |
| Foghorn Therapeutics |
Lantern Pharma and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lantern Pharma and Foghorn Therapeutics
The main advantage of trading using opposite Lantern Pharma and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Lantern Pharma vs. Cue Biopharma | Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Eliem Therapeutics | Lantern Pharma vs. Inhibrx |
| Foghorn Therapeutics vs. Cue Biopharma | Foghorn Therapeutics vs. Tff Pharmaceuticals | Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |